MarketBeat’s Top 5 Rated Small-Cap Stocks

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

or

Already have an account? Log in here.

Should You Invest $1,000 in Trevi Therapeutics Right Now?

Before you consider Trevi Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trevi Therapeutics wasn't on the list.

While Trevi Therapeutics currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Ryan Hasson
About The Author

Ryan Hasson

Contributing Author

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Atai Beckley (ATAI)
1.3906 of 5 stars
$7.35flatN/AN/AHold$10.56
LendingTree (TREE)
4.5084 of 5 stars
$35.22-1.5%N/A10.70Moderate Buy$53.60
CorMedix (CRMD)
4.7459 of 5 stars
$4.823.4%N/A3.75Moderate Buy$15.22
Trevi Therapeutics (TRVI)
2.1677 of 5 stars
$13.29-2.6%N/AN/AModerate Buy$27.08

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines